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Abstract
Equine chorionic girdle trophoblast cells play important endocrine and immune functions critical in supporting pregnancy. Very little 
is known about the genes and pathways that regulate chorionic girdle trophoblast development. Our aim was to identify genes and 
signalling pathways active in vivo in equine chorionic girdle trophoblast within a critical 7-days window. We exploited the late 
implantation of the equine conceptus to obtain trophoblast tissue. An Agilent equine 44K microarray was performed using RNA 
extracted from chorionic girdle and chorion (control) from equine pregnancy days 27, 30, 31 and 34 (n = 5), corresponding to the 
initiation of chorionic girdle trophoblast proliferation, differentiation and migration. Data were analysed using R packages limma and 
maSigPro, Ingenuity Pathway Analysis and DAVID and verified using qRT-PCR, promoter analysis, western blotting and migration 
assays. Microarray analysis showed gene expression (absolute log FC >2, FDR-adjusted P < 0.05) was rapidly and specifically induced 
in the chorionic girdle between days 27 and 34 (compared to day 27, day 30 = 116, day 31 = 317, day 34 = 781 genes). Pathway 
analysis identified 35 pathways modulated during chorionic girdle development (e.g. FGF, integrin, Rho GTPases, MAPK) including 
pathways that have limited description in mammalian trophoblast (e.g. IL-9, CD40 and CD28 signalling). Rho A and ERK/MAPK 
activity was confirmed as was a role for transcription factor ELF5 in regulation of the CGB promoter. The purity and accessibility of 
chorionic girdle trophoblast proved to be a powerful resource to identify candidate genes and pathways involved in early equine 
placental development.
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Introduction
Mammalian placental development requires a highly 
regulated series of cellular processes that transform a 
single layer of trophectoderm into a complex membrane 
that interacts intimately with maternal tissues. Although 
the anatomical structure of mature mammalian placentae 
is highly variable between species, the processes that 
lead to its formation are remarkably similar (Noronha & 
Antczak 2010, Soncin et al. 2015). Trophoblast cells that 
give rise to the placenta must undergo a period of rapid 
proliferation, followed by cell movement, differentiation, 
migration and in some species also invasion. Once 
trophoblast penetrate the endometrial epithelium, 
their immunomodulatory behaviour becomes critical 
to the prevention of immune-mediated pregnancy 
loss (Noronha & Antczak 2010, de Mestre et al. 2011, 
Moffett et  al. 2017). These cellular processes are 
difficult to study in human pregnancy due to the limited 
availability of tissues at key consecutive developmental 
stages. Consequently, much work has focused on rodent 
models of placentation (Underhill & Robins 2016), in 
vitro models of human pregnancy (Sibley 2017), together 
with comparative models of placentation (Imakawa et al. 
2017) that are both informative for understanding basic 
mammalian processes as well as being relevant to the 
species itself. Collectively these studies have revealed 
a number of genes and signalling pathways involved in 
placental development (Soncin et al. 2015, Gupta et al. 
2016, Haeger et  al. 2016) but exactly how important 
each of these pathways are for the multiple/overlapping 
processes that are occurring during development and 
whether these pathways are all active in vivo is less clear.
The early equine conceptus is unique in that 
it remains in a spherical shape surrounded by a 
glycoprotein capsule for the first 21 days of gestation. 
It is only after this capsule is lost that placental 
development begins in earnest (Allen & Wilsher 2009). 
Further, the late implantation in the horse (around day 
40) means it is remarkably accessible and remains 
essentially separate to maternal tissues throughout 
early placental development. This provides distinct 
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advantages over other species as it allows for isolation 
of pure populations of trophoblast cells with minimal 
manipulation (Noronha & Antczak 2010). By day 30 of 
gestation, the horse placenta is comprised of two main 
membranes. First, the allantochorion that undergoes 
rapid growth to form the diffuse epitheliochorial 
placenta of the horse primarily involved in nutritional 
exchange and later endocrine support of the pregnancy 
(Allen & Wilsher 2009). Second, the unique chorionic 
girdle which gives rise to the endometrial cups that 
secrete equine chorionic gonadotrophin (eCG) (Antczak 
et al. 2013) and modulate immunity to foetally derived 
tissues (de Mestre et al. 2010, 2011). Around day 27 of 
gestation, the trophoblast cells of the chorionic girdle 
begin to rapidly proliferate leading to multiple layers of 
trophoblast cells. Around day 30 of gestation chorionic 
girdle trophoblast cells receive a signal to terminally 
differentiate from uninucleate cells to mature eCG-
secreting binucleate cells (Cabrera-Sharp et  al. 2014) 
– a process which is close to complete by days 34–36 
of gestation. As the trophoblast cells differentiate they 
acquire a highly invasive phenotype and penetrate the 
endometrial luminal epithelium and migrate down the 
glands. Motility then ceases, cells enlarge and form what 
can be seen as mature endometrial cup trophoblast. The 
molecular mechanisms that regulate the development 
of the chorionic girdle, including the co-ordinated 
processes of proliferation, differentiation, cell movement 
and cell migration are poorly understood.
We recently identified bone morphogenetic protein 
(BMP) 4 signalling as a key regulator of trophoblast 
differentiation in the horse (Cabrera-Sharp et al. 2014). 
Whilst BMP4 was able to drive terminal differentiation 
and eCG secretion by the cells, not all cells differentiated 
in response to the ligand. This suggests other signals are 
also required to drive chorionic development. Expression 
of additional growth factor receptors during chorionic 
girdle development has also been shown (Stewart et al. 
1994, 1995, Allen et  al. 2007, 2017) although the 
functional importance and the activity of the associated 
molecular pathways has not been investigated. Previous 
studies have used equine-specific microarrays to study 
gene expression and/or imprinting in the placenta 
between days 8 and 14 and at day 34 (Klein & Troedsson 
2011, Brosnahan et al. 2012, Wang et al. 2013, Iqbal 
et al. 2014). These studies have found vital insights into 
the role of interleukin 22 (IL-22) in trophoblast invasive 
capacity (Brosnahan et al. 2012) and to factors likely to 
be important in the process of maternal recognition of 
pregnancy (Klein & Troedsson 2011). An understanding 
of the gene changes in the chorionic girdle during 
the time of trophoblast proliferation, differentiation, 
invasion and induction of eCG expression and secretion 
would offer key advances in the knowledge of these 
complex processes.
In this present study, we exploited the late implantation 
of the equine conceptus to obtain trophoblast tissue 
between days 27 and 34 of pregnancy from matched 
mare and stallion pairs. We used whole transcriptome 
profiling in order to measure and compare gene 
expression in chorionic girdle trophoblast and adjacent 
regressing chorion at pregnancy day 27 (initiation 
of proliferation and prior to differentiation), day 30 
(initiation of differentiation), day 31 (consolidation 
of differentiation and movement of cells) and day 
34 (when the majority of the trophoblast cells have 
terminally differentiated into binucleate eCG-secreting 
trophoblast and have started to obtain invasive qualities 
and immunomodulatory capacities). Differentially 
expressed genes were then identified to determine 
functions and signalling pathways whose activity was 
modulated over this critical period of trophoblast 
development. A selection of genes and pathways were 
subsequently validated.
Materials and methods
Animals and tissue collection
The study was approved by the Ethics Committee of the Royal 
Veterinary College and Home Office (PPL70/6944), and all 
animal procedures were performed in accordance with the 
Animals (Scientific Procedures) Act 1986 guidelines set by the 
Home Office, United Kingdom. Five mares (Equus caballus) 
aged between 3 and 7 years were of Dartmoor or Welsh breed 
and maintained in a paddock on grass and supplemented with 
hay over the winter. The reproductive cycle was manipulated 
using prostaglandin F2, and pregnancies were established 
as previously described (de Mestre et al. 2011) using semen 
from two stallions, standard artificial insemination and with 
ovulation induced using either 1500 IU hCG (Chorulon, MSD 
Animal Health, Milton Keynes, UK) intravenously or 2.1 mg 
Ovuplant (Dechra Veterinary Products, Shrewsbury, UK) 
subcutaneously. Ovulation was confirmed (day 0) and then 
pregnancies were monitored biweekly and on the day of 
isolation using transrectal ultrasonographic evaluation of the 
reproductive tract. Only those conceptuses confirmed to have 
a normal growth rate and normal anatomical development 
were included in the study. The same mare and stallion pairs 
(n = 5) (Supplementary Table  1 shows exceptions to this, 
see section on supplementary data given at the end of this 
article) were used to generate multiple conceptuses that were 
recovered at day 27, 30, 31 and 34 of pregnancy via non-
surgical uterine lavage as previously described (de Mestre 
et  al. 2008). Additional mare and stallion combinations 
(n = 3) generated conceptus tissue that was subsequently 
used for qRT-PCR and western blotting. Conceptuses were 
flushed into sterile phosphate buffered solution supplemented 
with 2× penicillin–streptomycin (5000 U/mL, Invitrogen 
Gibco) and placed immediately onto ice for transport to the 
laboratory. Conceptuses were dissected in PBS-2xPenStrep 
into components, chorionic girdle, chorion, allantochorion, 
yolk sac and foetus using a dissecting microscope (Zeiss). 
Dissected tissue was immediately snap-frozen in liquid 
nitrogen and stored at −80°C until RNA isolation or western 
blotting was performed.
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Isolation and qualitative and quantitative analysis 
of RNA
Total RNA was isolated from snap-frozen equine conceptus 
tissue, following homogenisation by QIAshredder (Qiagen), 
using a Qiagen RNeasy kit (Qiagen) as directed by the 
manufacturer. RNA was additionally treated with DNase on 
a column (Qiagen) as described by the manufacturer. RNA 
concentration and purity was determined by spectrophotometry, 
using the Nanodrop ND1000 spectrophotometer. The mean 
260/280 ratio was 2.10 (range 2.02–2.16). RNA quality was 
additionally assessed using Agilent 2100 Bioanalyser. The 
mean and median RNA integrity number was 9.1 (range 8–9.9) 
(Supplementary Fig. 1). Samples were stored at −80°C.
Microarray analysis
A 44K probe, single colour, equine Agilent Microarray (cyanine 
3-CTP; Agilent Technologies UK Ltd) was carried out by Dr. 
Lucille Rainbow, at the Centre for Genomic Research, The 
University of Liverpool. The above described DNase-treated 
RNA samples were submitted for analysis. Using RNA spike-in 
kits (Agilent Technologies UK Ltd) and via the manufacturer’s 
instructions, 50 ng of RNA sample was spiked with quality 
controls and run. cRNA was synthesised and amplified using 
the low input quick amp labelling kit via the manufacturer’s 
instructions (Agilent Technologies UK Ltd.). A specific T7 
RNA polymerase blend was used to generate fluorescent 
cRNA via incorporation of Cyanine 3-CTP. cRNA was purified 
with the RNeasy mini spin column kit (Qiagen), following 
the manufacturer’s protocol and concentration measured on 
the NanoDrop ND-1000 Spectrophotometer (Thermo Fisher 
Scientific). cRNA was hybridised to the microarray chip using 
the gene expression hybridisation kit (Agilent Technologies UK 
Ltd.), using the manufacturer’s instructions and then hybridised 
for 17 h at 65°C and 10 g using the Tecan HS Pro hybridisation 
station (Tecan group Ltd, Reading, UK). Microarray chips were 
washed with wash buffer and scanned by the Agilent DNA 
microarray scanner G2505C (Agilent Technologies UK Ltd). 
Samples were subjected to Agilent quality control measures, 
which all entities passed. Data have been submitted to NCBI 
Gene Expression Omnibus (GSE113072).
Following Principal Component Analysis (PCA) 
(Supplementary Fig. 2), a subset of two arrays (out of the total of 
40) were removed. These two samples were subsequently shown 
by qRT-PCR (data not shown) to express significantly aberrant 
levels of well-known markers of chorionic girdle cells such as 
chorionic gonadotrophin A (CGA), chorionic gonadotrophin B 
(CGB) and glial cells missing 1 (GCM1). Pre-processing steps 
of background correction and between-array normalisation 
were performed prior to analysis using the software packages 
R (http://www.r-project.org) and Bioconductor (http://www.
bioconductor.org). Differential expression analysis was 
performed using the R package limma (Ritchie et  al. 2015). 
Pre-processing steps of background correction and between-
array normalisation were implemented prior to analysis with 
differentially expressed genes identified using a linear model 
fit (lmFit) and an empirical Bayes method (eBayes). Genes 
with an absolute log fold change >2 and false discovery rate 
(FDR)-adjusted P < 0.05 were considered significant. Cluster 
gene analysis was performed using maSigPro (Conesa & Nueda 
2017) to group genes based on their expression profile. The cut-
off criteria used in maSigPro were fold change >2, R2 > 0.7 and 
P value of >0.01. DAVID Bioinformatics Resources 6.7 (Huang 
et al. 2009) functional annotation tool was used to evaluate 
signalling pathways within gene clusters. Gene lists were input 
to DAVID, selected to compare against ‘All species’ and gene 
names defined as ‘Official_gene_symbol’. Output signalling 
pathways in KEGG and PANTHER databases were considered, 
with parameters set to include pathways containing >5 genes 
with P < 0.01 (Fishers Exact test).
The normalised intensity data for chorionic girdle tissue 
only was also imported into Ingenuity Pathway Analysis (IPA) 
V119043121 software (Qiagen) for analysis of activation 
of canonical pathways and regulator effect networks. For 
analysis in IPA, one-way ANOVA (P < 0.05) applied across the 
timecourse was used to identify gene changes and pathway 
activation within the chorionic girdle. Output data were 
represented for canonical pathway activation and as summary 
lists of genes involved in effector networks of interest.
Multiplex qRT-PCR
Eight genes were selected from the array to fit the following 
criteria: upregulated or downregulated with a fold change 
2–5 or >20 in chorionic girdle between day 27 and day 34. 
As a control, Nuclear RNA Export Factor 1 (NXF1), a gene 
that remained constant in expression in the chorionic girdle 
between days 27 and 34, was also assessed. Primers were 
designed using GeXP eXpress Profile software in accordance to 
manufacturer instructions (Beckman Coulter, High Wycombe, 
UK), using mRNA sequences obtains from Ensembl genome 
browser (http://www.ensembl.org) (Supplementary Table  2). 
Target-specific reverse transcription and PCR amplification was 
performed as previously described (Hu et al. 2012, Xie et al. 
2012, Staines et al. 2016) and in accordance to manufacturer’s 
instructions (Beckman Coulter). In brief, a reverse transcription 
master mix was prepared as detailed in the GeXP starter kit 
(Beckman Coulter) and performed using a G-storm thermal 
cycler, using the programme protocol 48°C (1 min), 42°C 
(60 min), and 95°C (5 min). From this an aliquot was of each 
reverse transcription reaction was added to GenomeLab kit 
PCR master mix (Beckman Coulter) and Thermo-Start Taq DNA 
polymerase (Thermo Fisher Scientific). PCR reaction was again 
performed using G-storm thermal cycler with a 95°C activation 
step 10 min, followed by 35 cycles of 94°C (30 s), 55°C (30 s) 
and 70°C (60 s). Products were separated and quantified using 
CEQ 8000 Genetic Analysis System and GenomeLab Fragment 
Analysis software (Beckman Coulter). Genes of interest were 
normalised against the geo-mean of the two housekeeping 
genes, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
and succinate dehydrogenase complex, subunit A (SDHA), as 
previously described (Vandesompele et al. 2002).
Western blotting
Tissues were ground and lysed on ice in 200 µL lysis buffer 
containing: 150 mM sodium chloride (Sigma Aldrich, Haverhill, 
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UK), 1.0% (v/v) Nonidet P-40 (Sigma Aldrich), 0.5% (w/v) 
sodium deoxycholate (Sigma Aldrich), 0.1% (w/v) Sodium 
dodecyl sulphate (Sigma Aldrich), 50 mM Tris, pH 8.0 (Sigma 
Aldrich), 1 mM phenylmethylsulfonyl fluoride (Sigma Aldrich, 
added at time of use). Protein concentration was determined 
using Bradford assay (Bio-Rad Laboratories) and read using a 
Tecan infinite pro 200 plate reader, with Magellan 7 software 
(Tecan group Ltd.). Samples were stored at −20°C until use.
To assess total and phospho p44/42 extracellular signal 
regulated kinase (ERK1) protein expression, 50 µg of protein 
were loaded per well and separated by SDS-PAGE on a 
10% (wt/vol) polyacrylamide gel before being transferred to 
a polyvinylidene difluoride membrane (GE Healthcare Life 
Sciences) using a Mini-PROTEAN Tetra cell wet transfer unit 
(Bio-Rad Laboratories). The membranes were blocked in Tris-
buffered saline-Tween 20 containing 5% (wt/vol) nonfat milk 
(Marvel, Premier Foods Group, London, UK) for a total of 
3 h. Membranes were incubated overnight at 4°C in a 1:1000 
dilution of rabbit anti-human p44/42 total ERK or Rabbit anti-
human p44/42 phospho-ERK (Cell Signalling Technology, 
Leiden, The Netherlands) polyclonal antibodies each in Tris-
buffered saline-Tween 20 containing 5% (wt/vol) nonfat milk. 
Membranes were incubated with a 1:10,000 dilution of goat 
anti-rabbit IgG secondary antibody conjugated to horseradish 
peroxidase (Sigma) in Tris-buffered saline-Tween 20 containing 
5% (wt/vol) nonfat milk. Proteins were visualised by incubating 
with ECL plus detection reagents (PerkinElmer) and exposed 
onto Amersham hyperfilm ECL (GE Healthcare Lifesciences). 
As a loading control, membranes were stripped and reprobed 
for β-actin using a monoclonal mouse β-actin antibody (Sigma) 
at a dilution of 1:10,000.
Cloning of ELF5 and transactivation experiments
Full length equine ELF5 was cloned into the pCMV-Myc 
expression vector for co-transfection experiments. 
ELF5 was amplified by RT-PCR from equine day 34 
chorionic girdle cDNA using primers ELF5F CCATGGT 
ACCATGATGTTGGACTCAGTGAC and ACGGTCTAGAT 
CATAGCTTGTCCTCCTGCC. The pCMV-Myc vector and 
ELF5 PCR product were subjected to digest with XbaI and 
KpnI restriction and gel purified before ligation into pCMV-
myc. Successful cloning was assessed by analytical digest and 
Sanger sequencing. Truncated promoter constructs of specific 
lengths of the CG/LHB promoter were constructed via PCR 
from equine genomic DNA as previously described (Read 
et al. 2018). The immortalised cell line BeWo choriocarcinoma 
(BeWo) were cultured in DMEM supplemented with 10% 
foetal bovine serum, penicillin–streptomycin and l-glutamine, 
at 5% CO2 at 37°C. Cells were transiently transfected using 
Lipofectamine 2000 transfection reagent (Invitrogen) via 
the manufacturers’ instructions. Cells were transfected in 
24-well plates, at a confluency of 80%, with each of four LHB 
promoter inserts, alone or in combination with concentrations 
of pCMV-myc-ELF5 (0–150 ng), with DNA input controlled 
with an empty control pCMV-myc vector. Renilla was 
co-transfected as an internal control at a concentration of 
0.05 ng per well. Twenty-four post-transfection, cell lysates 
were harvested and promoter activity was measured using 
the Dual-luciferase Reporter Assay (Promega), as per the 
manufacturer’s instructions.
Culture of equine trophoblast and scratch assays
Chorionic girdles from day 34 conceptuses were dissected 
along the junction with the adjacent allantochorion, and 
chorion and girdle cells were gently scraped from the 
basement membrane and underlying mesodermal cell layer 
using a sterile scalpel blade and pure trophoblast cultured 
as previously described (Cabrera-Sharp et  al. 2014). Cells 
used in the study were between passage 3 and 5. Scratch 
assays were performed as previously described (Liang et  al. 
2007). Confluent monolayers of cells were scratched, both 
horizontally and vertically, to form a cross shaped wound. 
The same position on each arm of the wound was imaged at 
both time 0 and 24 h and the distance moved calculated by 
subtracting the width of the scratch at 24 h from that at time 0 
(following a preliminary experiment performed at 0, 8, 24 and 
48 h). Average width of a scratch was calculated by measuring 
its area and dividing by its length. At time 0 scratches were 
treated with either vehicle (ethanol used to resuspend the 
Rhosin) or Rhosin (Insight Biotech), 50 µM, a concentration 
that has been shown previously to inhibit Rho activation by 
approximately 80% (Shang et al. 2013). Following treatment 
cells showed no overt changes in morphology or cell death, 
maintaining a healthy monolayer appearance in all regions 
outside of the scratch. All experiments were done in duplicate 
and consisted of four independent wells per treatment, each 
well measured at four separate points, giving a total of 16 
measurements per treatment group per experiment. Statistical 
differences in cell movement were compared using a paired 
t-test in GraphPad Prism.
Results
Transcriptomic profile of chorionic girdle between 
days 27 and 34 of pregnancy
The data reported below used sibling conceptuses 
obtained at days 27, 30, 31 and 34 of pregnancy over 
two breeding seasons (total n = 38 samples, n = 4–5 each 
time point and each tissue). All conceptuses used in the 
study showed normal growth patterns and had normal 
placental and foetal anatomy as assessed clinically 
by transrectal ultrasonography and grossly under a 
dissecting microscope. For mare stallion pairs that 
did not generate a full set of conceptuses, half-sibling 
conceptuses were used (Supplementary Table 1).
The samples grouped well by tissue and gestational 
age (Supplementary Fig. 2). Analysis of global changes 
in gene expression revealed that 2207 probes were 
differentially expressed in the chorionic girdle and 
chorion across one or more time points or between 
tissues (Absolute log fold change >2, FDR-adjusted 
P < 0.05) (Supplementary Table  3). Gene expression 
in the control tissue (chorion) was remarkably stable 
throughout the gestation period studied, with only 11 
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genes differentially expressed in the chorion between 
days 27 and 34 (Table 1). In contrast, gene expression 
was rapidly induced in the chorionic girdle over the 
same time period (Table 1), with a peak of 781 genes 
differentially expressed in the chorionic girdle between 
day 27 and day 34. Consistent with a wave of genes 
that are turned on or on and off again during chorionic 
girdle development, there was significant overlap in the 
differential expression of genes at day 30, 31 and 34 
(Fig. 1A). Similarly, there was a significant increase in 
differential gene expression between the chorionic girdle 
and adjacent chorion between days 30 and 34 (Fig. 1B 
and Table  1). At day 27, no genes were differentially 
expressed between chorionic girdle and chorion but this 
rapidly changed during chorionic girdle development 
and by day 34 there were 1454 probes representing 
754 genes that were differentially regulated between the 
two tissues.
Validation of genes by qRT-PCR
To validate the microarray data, multiplex qRT-PCR was 
performed. Eight genes were selected from the array 
to fit the following criteria: up/downregulated with an 
absolute fold change between 2 and 5 or >20 in the 
chorionic girdle between day 27 and day 34. Of the 
eight genes analysed, six of the expression profiles 
(kruppel like factor 10 (KLF10), E74-like factor 5 (ELF5), 
paired box protein 6 (PAX6), SMAD family member 
7 (SMAD7), Cytochrome P450 17A1 (CYP17A1) 
and NXF1) were highly reproducible between the 
microarray data and multiplex qRT-PCR data (Fig. 2). The 
remaining two genes (S100 Calcium-Binding Protein 
A12 (S100A12) and Forkhead Box Protein 1 (FOXP1)) 
showed very similar patterns of expression in the two 
tissues, although statistical significance did not always 
match. The magnitude of the fold change in expression 
in the chorionic girdle between days differed between 
assays for some genes, although always remained in the 
same direction and, with the exception of FOXP1, also 
continued to fall into the same magnitude grouping used 
for its selection (2–5 or >20). The control gene, NXF1 
did not change in expression in the chorionic girdle at 
any time point between days 27 and 34. Although the 
fold change in expression was significantly different 
between the chorionic girdle and chorion for NXF1, the 
magnitude was always less than 1.5-fold.
Top upregulated and downregulated gene lists
The 20 top genes that were up/downregulated in the 
chorionic girdle between day 27 and 34 (absolute fold 
change >2, P < 0.05) are listed in Table 2 (up) and Table 3 
(down). Of the top 20 upregulated genes at day 30, 15 
genes also appeared in the top upregulated gene list for 
days 31 and/or 34. CGA, CGB, GCM1, MHC Class I, 
were all in the top 20 upregulated gene list. Interleukin 
22, previously shown to be highly upregulated in day 34 
chorionic girdle, was not one of the top 20 upregulated 
genes but was upregulated in day 34 chorionic girdle 
compared with day 27 chorionic girdle (log fold change 
3.94, P = 0.001). Top upregulated genes included 
fatty acid-binding protein 4 (FABP4) that peaked in 
expression at day 31 and transcription factor BCL6, 
highly upregulated at days 30 through 34. Immune 
genes, such as CXCL14, also featured in the top 20 list 
with expression highly induced as early as day 30.
Clustering of genes into expression patterns
Next, the R package SigPro software was used to cluster 
genes based on their expression patterns across both time 
and tissues. Nine different gene expression profiles were 
identified (Fig. 3) each containing between 13 and 374 
genes with an R2 regression fit of >0.7. Supplementary 
Table  4 provides full gene lists for each cluster. For 
Table 1 Number of probes and genes differentially expressed between tissues (CH, chorion; CG, chorionic girdle) and gestation day (days 
27–34).
Comparison Upregulated probes Upregulated genes Downregulated probes Downregulated genes
CH_27 vs CG_27 0 0 0 0
CH_27 vs CH_30 0 0 0 0
CH_27 vs CH_31 0 0 0 0
CH_27 vs CH_34 2 2 17 9
CG_27 vs CG_30 125 60 128 56
CG_27 vs CG_31 370 198 239 119
CG_27 vs CG_34 856 447 652 334
CH_30 vs CG_30 228 123 314 167
CH_30 vs CH_31 0 0 0 0
CH_30 vs CH_34 0 0 0 0
CG_30 vs CG_31 0 0 0 0
CG_30 vs CG_34 277 160 384 207
CH_31 vs CG_31 399 207 281 148
CH_31 vs CH_34 0 0 0 0
CG_31 vs CG_34 70 40 196 101
CH_34 vs CG_34 864 442 590 312
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example, genes included in the gene list for cluster 1 
increased in expression in the chorionic girdle (Fig. 3, 
cluster 1, red) and remained constant in expression in 
the chorion (green) over the same time period. Genes 
in clusters 1 and 7 which remained relatively constant 
in expression in the chorion and gradually increased or 
decreased in expression in the chorionic girdle between 
days 27 and 34 (cluster 1 and 7) were identified as 
genes and components of signalling pathways likely to 
be involved in cellular growth as either regulators of 
proliferation and/or differentiation or as markers of the 
change in the cells differentiation state. Gene lists from 
these two clusters were input into DAVID functional 
annotation tool, which identified 37 pathways (P < 0.01) 
(Table 4). Pathways of note were epidermal growth factor 
(EGF) and vascular endothelial growth factor (VEGF) 
signalling (11 and 10 entities respectively), integrin 
signalling (22 entities) and cytoskeletal regulation by 
Rho GTPases (10 entities). Genes that showed a similar 
pattern to clusters 1 and 7 but showed higher expression 
values by day 30/31 were clustered into groups 4 and 5. 
Four pathways were enriched in this gene list including 
genes related to the function of the lysosome (13 genes) 
and cytoskeletal regulation by Rho GTPases (9 entities). 
Genes that remained relatively constant in the chorion 
and rapidly increased in expression in the chorionic 
girdle at day 34 more consistent with genes associated 
with the acquisition of an invasive phenotype were also 
identified (Fig.  3 and Supplementary Table  3, clusters 
2 and 6). The pathways represented by clusters 2 and 
6 included focal adhesion (16 entities), chemokine 
signalling (11 entities) and tight junctions (10 entities) 
(Table  4). Cluster 3 revealed 83 genes that peak at 
days 30/31 specific to when differentiation is initiated 
(Supplementary Table 3, cluster 3 gene list). Clusters 3, 8 
and 9 were not further analysed in pathway analysis due 
to relatively low total number of genes on these lists.
Top regulator effector networks
Next, IPA was used to further explore the effector 
networks active during development of the chorionic 
girdle. Networks in the chorion were not assessed as 
only 11 genes were differentially expressed in day 34 
chorion (compared to day 27) and no genes differed 
in expression at other time points. The top 5 regulated 
effector networks at days 30, 31 and 34 (compared with 
day 27 chorionic girdle) are listed in Table 5. Activation 
scores were all high, suggesting that gene expression 
data is highly supportive of the networks identified. 
Consistent with key cellular processes known to occur 
during chorionic girdle development, two cellular 
processes were highly represented in these lists; cell 
movement/cell migration/invasion (6/15 networks) 
and proliferation/differentiation (5/15 networks). Cell 
movement and migration pathways demonstrated an 
increase in activation score over time from 8.485/6.062 
at day 30 to 11.25 at day 31 and scores of 10.8, 9.865 
and 8.014 for migratory pathways at day 34. By day 31, 
cell cycle regulation and S phase checkpoint control 
(activation score 9.925) were processes induced in 
trophoblast and this continues to day 34. Based on the 
directionality of the expression change in the microarray 
data, a number of upstream regulators of these effector 
networks were identified and are also listed in Table 5.
Top canonical pathways
IPA was also used to assess the activation of canonical 
pathways in the chorionic girdle between days 27 and 
34 of pregnancy using the full gene list. There were 
Figure 1 Global changes in gene expression in the chorionic girdle 
(CG) and adjacent chorion (CH) between days 27 and 34 of 
pregnancy. Venn diagrams showing the number of up (top number) 
and down (bottom number) regulated genes that changed in 
expression in the chorionic girdle compared day 27 chorionic girdle 
(A) and to the adjacent chorion (B).
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dynamic changes in predicted pathway activation in the 
chorionic girdle during development (Fig. 4). Out of a 
total of 533 pathways stored in the IPA software at the 
time of analysis, 35 pathways had an activation z-score 
of >2 or <−2 (P < 0.05) at one or more time points during 
chorionic girdle development (Fig. 4). These included 16 
pathways known to be associated with cell movement, 
12 pathways known to be involved in cellular immune 
responses and 12 pathways associated with cell cycle 
regulation and/or differentiation (Fig.  4). There was 
a predominance of movement pathways related to 
signalling by Rho GTPases including activation of RhoA, 
regulation of actin-based motility by Rho and inhibition 
of the inhibitory signal, RhoGDI signalling (Fig.  4). 
Cell cycle pathways with positive activation scores 
included ILK signalling, aryl hydrocarbon receptor 
signalling (which peaked at day 30 around initiation of 
differentiation) and TWEAK signalling.
Validation of genes and pathways
Next, in order to further explore the activity of the 
genes and pathways identified above, one gene and two 
pathways were selected for further investigation.
ELF5 transactivates the CGB promoter
Ets family transcription factor ELF5 was selected 
from the genes confirmed by qRT-PCR for further 
investigation due to its temporal expression profile that 
suggested a possible role in regulation of trophoblast 
development. RT-PCR amplification of ELF5 and ELF4 
(a related family member) genes in equine chorionic 
girdle and control chorion tissues from gestational ages 
27 to 34 days (Fig. 5A) showed that ELF5 was expressed 
in the chorionic girdle and chorion at all time points, 
with evidently higher expression it the chorionic girdle 
compared to the chorion. Gene expression of ELF4 was 
not detectable in any equine conceptus tissues tested, 
regardless of gestational age. Expression in control 
spleen tissue demonstrated successful amplification of 
the ELF4 gene (Fig. 5A). Western blot analysis confirmed 
the presence of an approximately 37 kDa protein in the 
chorionic girdle similar to the predicted size of ELF5 
(31 kDa) (Supplementary Fig. 3).
This expression profile in the chorionic girdle 
combined with bioinformatics analysis of the CG/LH 
promoter that revealed 24 predicted ELF5-binding sites 
(data not shown) led us to hypothesise that ELF5 may 
play a role in inducing CG/LHB expression, a key gene 
induced during differentiation of chorionic girdle cells 
and the rate-limiting subunit required for eCG production 
(de Mestre et  al. 2009). To explore this further, we 
used the expression data generated on the microarray 
to determine if an association existed between CG/
LHB and ELF5 expression in all chorion and chorionic 
tissues (Fig.  5B). ELF5 and CG/LHB mRNA expression 
in individual chorionic girdle and chorion tissues was 
strongly positively correlated (R2 = 0.80, P < 0.0001).
To determine whether activity of the CG/LHB 
promoter was driven by ELF5, co-transfections were 
carried out in COS7 cells using 250 ng of four truncated 
CG/LHB promoter inserts (Read et  al. 2018), either 
alone, with addition of 150 ng pCMV-myc-Empty vector, 
or with 150 ng pCMV-myc-ELF5 (Supplementary Fig. 4). 
Promoter activity was assessed using luciferase assays 
(Fig. 5C). The 2157 bp CG/LHB construct that contained 
24 predicted binding sites for ELF5 was transactivated 
by pCMV-myc-ELF5, 8.4-fold (s.e.m. = ±4.4, P = 0.0002) 
over pCMV-myc-Empty. The 1888 bp CG/LHB promoter, 
Figure 2 Validation of microarray data using multiplex qRT-PCR. 8 genes selected from microarray data were validated in expression via 
multiplex qRT-PCR. Microarray data is plotted on the left hand axes, alongside multiplex qRT-PCR data plotted on the right hand axes of each 
pair of graphs. All fold changes are shown compared with day 27 chorionic girdle. (A) Genes selected for validation with an upregulation (i) 2–5 
fold and (ii) >20 fold, in the chorionic girdle between days 27 and 34 of pregnancy in microarray data. (B) Genes selected for validation with a 
downregulation (i) 2–5 fold and (ii) >20 fold, in the chorionic girdle between days 27 and 34 of pregnancy in microarray data. (C) Gene selected 
with no change in the chorionic girdle between days 27 and 34 of pregnancy, based on microarray data. *P < 0.05, **P < 0.01, ***P < 0.001, 
****P < 0.0001 (compared to day 27 chorionic girdle), #P < 0.05, ##P < 0.01, ###P < 0.001, ####P < 0.0001 (compared to chorion at same time point) 
(two-way ANOVA).
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containing 11 predicted binding sites was driven 5.8-
fold (s.e.m. = ±2 P = 0.0023) by pCMV-myc-ELF5 above 
pCMV-myc-Empty. No significant increase in promoter 
activity was observed for the pGL3-basic, pGL3-119 (no 
predicted sites) or pGL3-335 (1 predicted site) promoter 
constructs when co-transfected with pCMV-myc-ELF5. 
The pCMV-myc-Empty vector had no driving activity on 
any of the promoter constructs.
Validation of classical MAPK signalling in the 
chorionic girdle
Signalling molecules downstream of a number of 
pathways predicted above to be modulated during 
chorionic girdle development (FGF, EGF and VEGF) 
included classical mitogen-activated protein kinase 
(MAPK) signalling molecules, ERK1/2. Western blot 
analysis demonstrated that ERK/MAPK pathways were 
active in the both the chorionic girdle and chorion at 
all time points as demonstrated by detectable p44/p42 
protein bands (Fig. 6A). An increase in phosphorylation 
of the p44 (ERK2) protein at day 30 of pregnancy in the 
chorionic girdle was observed with no apparent change 
in the phosphorylation of the p42 protein (ERK1). 
Densitometry analysis of phospho ERK1/2/Total ERK1/2 
(n = 3 conceptuses per time point) showed a significant 
increase in phospho-ERK at day 30 compared with 
day 27 in chorionic girdle (P = 0.0348) but not chorion 
(Fig. 6B). In addition, using qRT-PCR, we assessed the 
expression profile of ERK1/2-regulated transcription 
Table 2 Top 20 upregulated genes in the chorionic girdle at day 30, 31 and 34 all compared to day 27 chorionic girdle.
Gene symbol^ Gene function LogFC day 30 LogFC day 31 LogFC day 34
FABP4 Fatty acid binding protein 5.81310*** 7.12020**** 5.48164***
CG Glycoprotein hormone alpha subunit 5.24752** 6.85655*** 8.54458****
Unameda Unknown 4.62192**
BCL6 Transcription factor 4.28718*** 5.05434**** 5.70755****
SBSPON Scavenger receptor activity 4.14721** 5.04306*** 5.67806****
ENSECAT00000017968 Uncharacterised protein 3.61386** 4.59892****
FFAR2 G-protein-coupled receptor 3.36892* 5.03815*** 6.84478****
FGF7 Epithelial cell-specific growth factor 3.35574*** 4.99731****
Unamedb Unknown 3.27125** 4.00893**** 4.90052****
PSMB9 Proteasome subunit 3.21874** 4.40427**** 5.09380****
ENSECAT00000015366 Uncharacterised protein 2.91600*** 3.80865****
PLAC9 Placenta specific gene 2.88399** 4.03647****
CXCL14 Cytokine 2.82875**
CCNB1 Regulatory protein involved in mitosis 2.77803**
ARG2 Arginase activity 2.76454***
MYBL2 Transcription factor 2.66493**
RRM2 Ribonucleotide reductase 2.64996** 3.27003***
Unamedc Unknown 2.58010* 3.43442*** 5.48339****
SERPINE2 Inhibitor of serine protease 2.52432* 3.32343** 5.53857****
GCM1 Transcription factor 2.44777* 3.51574***
Unamedd Unknown 4.93379***
Unamede Unknown 3.51056*** 5.97793****
FAM227B Transcription factor 3.31251****
MHC Class I Central role in the immune system 3.23287***
TAF4B Selective coactivator of transcription 3.20532****
TCN1 Vitamin B-12 binding protein 8.97029****
LAMB3 Basement membrane protein 7.03224****
Unamedf Unknown 6.30324****
ENSECAT00000001317 Known protein coding 6.09937****
Unamedg Unknown 5.95520****
ITGA2 Transmembrane receptor subunit 5.79772****
CADM1 Cell adhesion molecule 5.30317****
Unamedh Unknown 4.92632****
Unamedi Unknown 4.89318****
CGB Chorionic gonadotrophin B-subunit 6.52371****
Of the top 20 upregulated genes at day 31, 15 also appeared on the list for day 30. Of the top 20 genes upregulated at day 34, 10 genes 
appeared on the lists for day 30 or 31.
*P < 0.05; **P < 0.01; ***P < 0.001; ^unamed gene with Ensembl number; aEquine placenta cDNA Library Equus caballus cDNA clone 
HL02016B1B10, DN509596; bEquine Articular Cartilage cDNA Library Equus caballus cDNA clone CT020024A10D12, CX599557; cEquine 
placenta cDNA Library Equus caballus cDNA clone HL02019B2G06, mRNA sequence, DN510553; dEquine placenta cDNA Library Equus 
caballus cDNA clone HL02016B1B10, mRNA sequence (DN509596); eEquine placenta cDNA Library Equus caballus cDNA clone 
HL020001000_PLATE_E04_29_023, mRNA sequence (DN507748); fEquine Articular Cartilage cDNA Library Equus caballus cDNA clone 
CT020021B10E08, mRNA sequence (CX598679); gEquus caballus contig07293.EqcaPBMC mRNA sequence (JL622886); hEquus caballus 
contig05471.EqcaPBMC mRNA sequence (JL621232); iEquine placenta cDNA Library Equus caballus cDNA clone HL02014A2G04, mRNA 
sequence (DN508969).
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factors, serum response factor (SRF) and CRE-binding 
protein 1 (CREB1) in the chorionic girdle. Correlating 
with the increase in ERK1/2 activity at day 30, SRF and 
CREB1 expression significantly increased at day 31 in 
the chorionic girdle when compared to day 27 (Fig. 6C).
RhoA is involved in migration of equine chorionic 
girdle trophoblast
A number of pathways related to Rho signalling were 
identified in Fig.  4. In order to further explore the 
functionality of these pathway, primary day 34 equine 
trophoblast cells were cultured in the presence or 
absence of Rho inhibitor Rhosin (50 µM) and trophoblast 
migration assessed using a scratch assay (Fig. 7A). There 
was no change in the morphology of the cells or evidence 
of cell death following treatment with Rhosin or ethanol 
(control). Treatment of chorionic girdle trophoblast 
with 50 µM Rhosin resulted in a significant reduction 
in trophoblast migration into the scratch compared to 
ethanol control treated cells (P < 0.001) (n = 8, 4 readings 
per scratch) (Fig. 7B).
Discussion
Chorionic girdle development requires a number of 
co-ordinated processes that must occur in a timely 
and controlled manner. Establishing the global gene 
expression profile for genetically paired conceptuses 
over a 7-day period of pregnancy (day 27–34) has 
provided a powerful insight into the genetic landscape 
of the trophoblast cells as they terminally differentiated 
from uninucleate trophoblast into eCG-secreting 
binucleate trophoblast with an invasive phenotype. 
Fluctuations in gene expression were both dynamic 
and very specific to the CG whilst the adjacent chorion 
Table 3 Top 20 downregulated genes in the chorionic girdle at day 30, 31 and 34 all compared to day 27 chorionic girdle.
Gene symbol^ Gene function LogFC day 30 LogFC day 31 LogFC day 34
FABP1 Fatty acid binding protein 3.42092****
GPR162 G protein-coupled receptor 3.41190****
PTGS2 Enzyme for prostaglandin synthesis 3.33766**** 3.98743*** 4.98492****
RDH16L Enzyme, retinol dehydrogenase 3.26851**** 4.19061**** 4.88511****
IL1B Cytokine 3.25615**** 4.55809** 4.92065**
Unameda Unknown 3.19614**** 5.10370**** 6.14734****
Unamedb Unknown 3.16932**** 4.18707**** 4.69047****
ENSECAT00000022537 Uncharacterised protein 3.15012**** 4.21925**** 5.01506****
ENSECAT00000007031 Uncharacterised protein 3.00171****
ACTG2 Cytoskeletal protein 3.00165****
FMO1 Oxioreductase 2.89347** 3.89842**** 4.87058****
CA7 Reversible hydration of CO2 2.83819**** 3.84538****
HSD3B1 Bifunctional enzyme 2.75848****
ENSECAT00000019764 Uncharacterised protein 2.63330**** 3.64952****
APL1 membrane-associated glycoprotein 2.61260**** 4.56274**** 4.66107****
ENSECAT00000020332 Uncharacterised protein 2.54894****
LGMN Enzyme, cysteine protease 2.52946****
MT Golgi localised protein 2.51741****
ENSECAT00000021165 Uncharacterised protein 2.50448**** 3.54138****
CYP17A1 Enzyme, cytokine p450 2.50254**** 3.70293**** 4.89858****
Unamedc Unknown 4.11917****
TAGLN3 Actin filament binding 4.11782**** 5.72992****
LHFPL1 Transmembrane protein 4.01210*** 5.24291****
ENSECAT00000024713 Uncharacterised protein 3.74453*** 5.23593****
CPVL Carboxypeptidase 3.73216*** 5.52317****
PLXNB1 Regulation of actin cytoskeleton 3.64882****
ENSECAT00000016216 Uncharacterised protein 3.64030**** 4.73441****
ENSECAT00000006927 Uncharacterised protein 5.32239****
SLC46A1 Transmembrane folate transporter 5.05205****
Unamedd Unknown 5.02691****
Unamede Unknown 4.78917****
CA4 Reversible hydration of CO2 4.69078****
PLA2G10 Enzyme, phospholipase 4.57344****
Of the top 20 upregulated genes at day 31, 16 also appeared on the list for day 30. Of the top 20 genes upregulated at day 34, 10 genes 
appeared on the lists for day 30 or 31.
*P < 0.05; **P < 0.01; ***P < 0.001; ^Ensembl number listed for unnamed genes; ^Unamed gene with Ensembl number; aEquine placenta cDNA 
Library Equus caballus cDNA clone HL020010000_PLATE_G06_47_050, mRNA sequence (DN508408); bEquine placenta cDNA Library Equus 
caballus cDNA clone HL02021A2F04, mRNA sequence (DN510935); cEquine placenta cDNA Library Equus caballus cDNA clone 
HL02019B1D12, mRNA sequence (DN510457); dEquine placenta cDNA Library Equus caballus cDNA clone HL020002000_PLATE_
G01_7_004, mRNA sequence (DN507842); eEquine Articular Cartilage cDNA Library Equus caballus cDNA clone CT02041A1D02, mRNA 
sequence (CX605310).
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had remarkably stable gene expression over the 
same time period. The abundant genes and pathways 
identified were highly consistent across laboratory and 
bioinformatic approaches, with three of these, ELF5 
function, ERK1/2 activity and Rho A function, further 
confirmed in functional assays.
Initial PCA visualisation of grouping of the tissues 
demonstrated distinct gene expression profiles in the 
chorionic girdle at all time points assessed, whilst in 
contrast, chorion tissues from all time points were 
genetically identical. In total, only 11 genes were 
differentially expressed in the control tissue, chorion 
compared with 1625 in the chorionic girdle. Although 
chorionic girdle trophoblast at day 30/31 are still 
primarily uninucleate trophoblast, the gene profile 
already had substantially shifted (116 and 317 genes 
respectively) when compared to day 27 cells. This 
corresponds to the time at which a large proportion 
of chorionic girdle trophoblasts rapidly proliferate 
and undergo differentiation to become terminally 
differentiated binucleate trophoblast cells and is also the 
period immediately prior to the significant induction of 
eCG expression (de Mestre et al. 2009, Read et al. 2018). 
The genes and pathways switched on/off in this early 
period in girdle development will provide important 
clues to the initiators of proliferation, differentiation and 
eCG expression. For example, fatty acid-binding protein 
FABP4, a gene known to regulate both proliferation 
and differentiation genes in human trophoblast cell line 
HTR8/SVneo (Basak et al. 2018), was found to peak in 
expression at day 31. C-X-C Motif Chemokine Ligand 14 
(CXCL14) expressed in human villous cytotrophoblast 
(Kuang et  al. 2009) and known to negatively regulate 
trophoblast invasion was highly induced by day 30. It 
is plausible that CXCL14 is playing a similar role in the 
chorionic girdle, preventing premature invasion of early 
forming binucleate cells into the endometrium, which 
usually does not take place until day 34–38.
In order to further establish that changes in gene 
expression observed in microarray analysis were truly 
representative of the biology of the trophoblast cells eight 
genes were verified by qRT-PCR and all demonstrated 
the same expression pattern to that of the microarray. 
A small number of genes shown previously to be 
expressed in day 34 chorionic girdle (Bacon et al. 2002, 
de Mestre et al. 2009, Brosnahan et al. 2012) featured 
on gene and signalling pathway lists providing further 
confirmation of the validity of the large dataset. For 
example, gene cluster analysis identified the SMAD1/5 
arm of the TGFβ signalling pathway to contain multiple 
differentially regulated genes in the chorionic girdle, 
including BMP4, its receptor bone morphogenic protein 
receptor 2 (BMPRII) and SMAD1/5, all consistent with 
a known function of this pathway in equine trophoblast 
(Cabrera-Sharp et al. 2014). EGF signalling in chorionic 
girdle cells as measured by canonical pathway analysis 
increased in activity in the chorionic girdle supporting 
previously reported expression profiles of EGF and EGF 
receptors in the chorionic girdle (Stewart et  al. 1994, 
Allen et al. 2017). The function of EGF in the chorionic 
girdle is not known but in human trophoblast, EGF has 
been shown to promote proliferation through activation 
of AKT and ERK1/2 signalling downstream of EGFR 
(Fock et  al. 2015, Costa et  al. 2016). The ERK/MAPK 
signalling pathway was confirmed here to be functional 
in chorionic girdle trophoblasts, increasing in activity at 
day 30 of pregnancy when compared to day 27. It is 
therefore likely that EGF signalling acting via ERK1/2 is 
indeed active in the chorionic girdle.
Phosphorylation of p44/p42 and nuclear translocation 
is thought to be important for cell cycle re-entry into 
S phase in response to mitogenic activators (Brunet 
et  al. 1999). S phase checkpoint effector networks 
are identified at days 31 and 34 here, so it is possible 
that the MAPK/ERK signalling pathway is crucial for 
this regulation. Other described roles for the MAPK/
Figure 3 Clusters of similarly regulated genes 
in the chorionic girdle, identified using 
maSigPro software. Genes with a fold change 
>2 (P < 0.05) between days 27 and 34 of 
gestation in the chorionic girdle, were 
grouped by maSigPro software into the nine 
most likely expression profiles. Chorionic 
girdle is shown in red and chorion in green. 
Plotted is the median expression profile of 
genes within each cluster. Probe numbers and 
corresponding gene numbers (including those 
unnamed genes) are provided below each 
cluster. Gene lists for each cluster can be 
found in Supplementary Table 4.
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ERK pathway include regulation of cellular growth 
differentiation (Brunet et  al. 1999, Dumaz & Marais 
2005). Due to the ubiquitous nature of the MAPK/
ERK pathway, it is likely that it plays roles in multiple 
cellular processes during chorionic girdle development, 
perhaps activating the cell cycle at day 30-31 and later 
differentiation at day 31-34.
Fibroblast growth factor 7 (FGF7), a growth factor 
expressed by bovine immature trophoblast giant cells 
(Pfarrer et  al. 2006), was significantly upregulated 
Table 4 Pathways and processes enriched in gene clusters.
Term No. of genes P value
Cluster 3
 Spliceosome 5 0.00016
Clusters 4 and 5
 Lysosome 13 0.00110
 Cytoskeletal regulation by Rho GTPase 9 0.00610
 Pathogenic Escherichia coli infection 8 0.00230
 Ether lipid metabolism 6 0.00290
Clusters 1 and 7
 Pathways in cancer 22 0.00002
 Integrin signalling pathway 22 0.00000
 Inflammation mediated by chemokine and cytokine signalling pathway 21 0.00007
 Focal adhesion 19 0.00000
 Regulation of actin cytoskeleton 17 0.00003
 Angiogenesis 14 0.00320
 PDGF signalling pathway 13 0.00140
 Chemokine signalling pathway 12 0.00260
 Neurotrophin signalling pathway 12 0.00006
 EGF signalling pathway 11 0.00180
 Cytoskeletal regulation by Rho GTPase 10 0.00083
 VEGF signalling pathway 10 0.00005
 Small cell lung cancer 10 0.00004
 Renal cell carcinoma 10 0.00001
 Tight junction 9 0.00660
 Endothelin signalling pathway 9 0.00110
 Prostate cancer 9 0.00038
 Chronic myeloid leukaemia 9 0.00010
 T cell receptor signalling pathway 8 0.00580
 Fc gamma R-mediated phagocytosis 8 0.00260
 Insulin signalling pathway 8 0.00210
 ErbB signalling pathway 7 0.00620
 Progesterone mediated oocyte maturation 7 0.00590
 ECM-receptor interaction 7 0.00510
 Colorectal cancer 7 0.00510
 Fc epsilon RI signalling pathway 7 0.00340
 Pancreatic cancer 7 0.00210
 Melanoma 7 0.00200
 Glioma 7 0.00097
 Acute myeloid leukaemia 7 0.00059
 Endometrial cancer 7 0.00030
 Valine, leucine and isoleucine degradation 7 0.00010
 p53 pathway feedback loops 2 6 0.00750
 Non-small cell lung cancer 6 0.00230
 Bladder cancer 6 0.00059
 Glycerolipid metabolism 5 0.00530
 Thyroid cancer 5 0.00071
Clusters 2 and 6
 Focal adhesion 16 0.00001
 Chemokine signalling pathway 11 0.00410
 Adherens junction 10 0.00001
 Tight junction 10 0.00110
 Histamine H1 receptor mediated signalling pathway 6 0.00076
 Vibrio cholera infection 5 0.00950
 GABA-B receptor II signalling 5 0.00350
The genes identified in maSigPro clusters 3, 4 and 5, 1 and 7 and 2 and 6 were mapped onto pathways in the KEGG and PANTHER databases. 
Pathways containing a minimum of five cluster genes (P < 0.01) were considered biologically relevant. Shown are the pathway identifiers, the 
number of cluster genes present in the pathway and the P value (Fishers Exact).
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between day 27 and 34, as was the related family 
member fibroblast growth factor-binding protein 1 
(FGFBP1). Previous studies have reported fibroblast 
growth factor 2 (FGF2), its receptors (fibroblast growth 
factor receptor 1-4 (FGFR1-4)) and FGF-binding protein 
to be expressed in equine trophectoderm earlier in 
pregnancy between days 14 and 28 (de Ruijter-Villani 
et al. 2013). Supportive of a possible autocrine function 
for FGF7 in the chorionic girdle, FGF signalling was 
identified in gene cluster analysis with 9 FGF regulated 
genes found to be induced/repressed between days 27 
and 34 and downstream ERK1/2 activity confirmed in 
chorionic girdle by western blot. This is consistent with 
other species, where FGF proteins are thought to play 
a key role in trophoblast development including hCG 
production (Jeong et  al. 2016) via signalling through 
ERK (Taniguchi et  al. 2000, Yang et  al. 2011, Kunath 
et al. 2014). The role for FGF signalling in the equine 
placenta remains unknown, but data here suggest an 
autocrine function for FGF signalling in trophoblast 
development in the chorionic girdle. Based on its high 
expression pattern, it is plausible that it may also act 
in a paracrine manner on adjacent tissues such as the 
allantochorion thus co-ordinating chorionic girdle 
development and implantation.
ELF5 mRNA expression was found to be one of the 
most markedly induced genes between days 27 and 
34 with maximal expression at day 34. Transactivation 
studies demonstrated that ELF5 was able to drive the 
CG/LHB promoter between the regions of 335 and 
2500 bp relative to the translation start codon suggesting 
it may play a role in biochemical differentiation of 
trophoblast. The large number of potential ELF5-binding 
sites in this region suggests that ELF5 may drive promoter 
activity by acting directly to multiple sites in the distal 
promoter, although further work is required. ELF5 was 
considered widely considered to be a ‘gatekeeper’ 
of stem cell status in mouse studies (Hemberger et al. 
2010, Pearton et al. 2011, 2014). More recently, work 
suggests that ELF5s function changes in a concentration-
dependent manner with high levels of ELF5 triggering 
trophoblast differentiation (Latos et al. 2015) achieved 
through an interaction with transcription factor AP-2 
gamma (TFAP2C). Interestingly, we did detect ELF5 
transcript in day 27 chorionic girdle, albeit at much 
lower levels (data not shown). Therefore, it is plausible 
Table 5 Top 5 effector networks and associated upstream regulators identified using IPA.
Day of gestation
Top upregulated upstream regulators (vs 
D27 ChG) Functions of regulated effector networks Consistency score
D30 1. GLIS2, IgG, IHH,MAP2K1, MAP2K1/2, 
MAP2K3, miR141-3p, PTHLH
Cell movement of tumour cells 8.485
2. Akt, CTNNB1, ERK, ETV4, Histone H3, 
PRKCZ
Failure of kidney, glomerulosclerosis 7.778
3. ETV4, PML, SDCBP, TBX3, TFEB Accumulation of lipid, cell movement of tumour cells, 
blood vessel development
6.306
4. ETV4, SP11, TLR4 Cell movement of tumour cells, fibrosis of kidney, urinary 
system morphology
6.062
5. E2f, EP400, LYL1, RAF1, TBX2, TFDP1 Size of animal, size of embryo 5.277
D31 1. BGN, ETV4, ETV5, GLIS1, HNRNPAB, 
MAP2K1/2, PLCD1, PTHLH, SOCS1, SRC 
(family)
Migration of cancer cells 11.250
2. AHR, BMIP3L, CCND1, E2F2, E2F6, 
EIF4G1, let-7, PPM1D, RBL1, STUB1, 
TBX2
Repair of DNA, S phase checkpoint control 9.922
3. E2f, EP400, Pka, TBX2, TFDP1 Proliferation of heart cells, size of embryo, quantity of 
brain cells
4.750
4. CDKN1A, E2F1, HDAC1, let-7, mir-10, 
miR16-5p, Rb, TBX2
S phase checkpoint control 4.596
5. HNRNPAB, MAP3KB, NOS2, POU5F1, 
SATB1, SPDEF
Progression of tumour 3.273
D34 1. APC, ETV4, ETV5, GLIS2, MAP3K8, 
PLCD1, SPARC, WISP2
Cell movement of lymphocytes, migration of cancer cells 10.800
2. BMP15, BMPR1A, HNRNPAB, PLA2G5, 
TBX5
Angiogenesis, cell movement of lymphocytes, colony 
formation of cells movement of cancer cells, proliferation 
of muscle cells
9.865
3. GLIS2, MAP2K1/2, PLCD1, SMAD3, SRC 
family, TGFB3, WISP2
Migration of tumour cells 8.014
4. CCND1, E2F2, E2F6, EIF4G1, let-7, 
PPM1D, RBL1, STUB1, TBX2
Repair of DNA, S phase checkpoint control 7.649
5. Akt, CDKN1A, E2F1, FGF2, HDAC1, 
let-7, mir-10, miR125b-5p, miR16-5p, 
PTEN, Rb, TBX2
S phase checkpoint control 5.303
The top 5 upregulated regulator effect networks at each time point, as compared to day 27 chorionic girdle are shown. Identified upstream 
regulators and their downstream cellular effects are shown, with consistency score for the pathway (z-score >2, P < 0.05, IPA).
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Figure 4 Activation of canonical pathways in the chorionic girdle during day 27–34 of pregnancy. IPA was used to identify activation or 
repression of canonical pathways in the chorionic girdle between days 27 and 34 of gestation. All pathways identified by the programme to 
have an activation (z-score) score of > or <2 and P < 0.05 are shown with green indicating activation and red inactivation. Pathways were 
grouped according to known functions.
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that the chorionic girdle trophoblast utilise ELF5 in 
a similar manner to mouse cells, with low levels that 
ELF5 playing a role in maintaining the stem cell status of 
progenitor chorionic girdle cells (supported here in the 
pathway analysis which show loss of stem cell pathways 
between day 27 and 34) and high levels of ELF5 at day 
34 driving the switch to differentiation and induction of 
CG/LHB expression.
Proliferation pathways consistently arose in regulator 
effect networks at all time points and were represented 
in canonical pathway analysis by pathways, such as 
endothelin 1 signalling and cyclin dependent kinase 5 
(CDK5) signalling. The kinetics of these pathways suggest 
a reduced, yet ongoing requirement for trophoblast 
proliferation throughout chorionic girdle development. 
The upstream regulator EP400 was identified as a top 
upstream regulator at days 31 and 34 of pregnancy 
and is known to play a role in cellular proliferation in 
other cells types (Mattera et al. 2009). The majority of 
other signalling data suggests repression of proliferation 
signalling pathways. Endothelin signalling in cancer 
cells is known to play diverse roles in proliferation, 
apoptosis and migration (Rosano et al. 2013) and TNF-
related weak inducer of apoptosis (TWEAK) signalling is 
well defined to promote proliferation of cardiomyocytes 
(Novoyatleva et  al. 2010). It is likely that pathway 
suppression represents a continuous but proportionally 
decreasing population of proliferating cells, as increasing 
numbers of chorionic girdle trophoblasts terminally 
differentiate, losing their proliferative capacity.
A number of pathways associated with cellular 
differentiation emerged, including those involved in 
cell cycle regulation, loss of pluripotency and AHR and 
MAPK/ERK signalling pathways. Repair of DNA and S 
phase checkpoint control were consistently identified 
throughout chorionic girdle development as important 
effector networks. Additionally, transcription factors 
E2 factor (E2F) and E2 factor 2 (E2F2) were identified 
as top upstream regulators at all time points in the 
chorionic girdle. The canonical E2Fs (E2F1, E2F2 and 
E2F3) regulate trophoblast giant cell differentiation 
through the promotion of the cell endocycle, via 
regulation of cyclin E and S phase control (Chen et al. 
2012, Ouseph et  al. 2012). A conserved role for E2F 
proteins in regulation of cyclins D and E and subsequent 
G1 cell cycle progression has been observed in human 
placental cell differentiation (Ohtani et  al. 1995). The 
data generated here suggest that the role for E2F and 
E2F2 are also conserved in the regulation of the cell cycle 
in differentiating equine chorionic girdle trophoblasts. 
Canonical pathway heatmaps indicated that cyclin 
signalling pathways were upregulated in the chorionic 
girdle at day 30 of pregnancy, with a subsequent loss 
of activation at days 31 and 34. Equine trophoblasts 
Figure 6 Activity of the ERK1/2 pathway in the chorionic girdle. (A) Representative western (n = 3) for phospho-ERK and total ERK in one 
timecourse set of chorionic girdle and chorion tissues. Shown are the phosphorylated and total p44 (ERK2) and p42 (ERK1) protein. (B) 
Densitometry analysis of western blots for phospho/Total ERK (P44/42) n = 3. *P < 0.05. (C) Multiplex qRT-PCR was used to quantify mRNA 
expression of SRF and CREB1. *P < 0.05, **P < 0.01, ****P < 0.0001 (compared to day 27 chorionic girdle), ###P < 0.001 (compared to chorion at 
same timepoint) (two-way ANOVA).
Figure 5 ELF5 mRNA is expressed in chorionic girdle trophoblast 
cells, correlates with CG/LHB mRNA expression and drives CG/LHB 
promoter activity. (A) ELF4 and ELF5 mRNA in equine chorionic 
girdle and control chorion tissues at days 27, 30, 31 and 34 of 
gestation as shown by RT-PCR with B-actin used as a loading control. 
Kidney and spleen tissues are used as control. (B) Correlation 
between ELF5 and CGB mRNA expression in individual day 30–34 
equine chorionic girdle and chorion samples. Microarray expression 
data is normalised to the median in R software and displayed as fold 
change. (C) Truncated promoter inserts, as shown with annotated 
potential ELF5 binding sites, were transfected into COS7 cells alone, 
in the presence of 150 ng pCMV-myc-Empty or 150 ng pCMV-myc-
ELF5. Numbers are relative to Translation Start Site. Promoter activity 
is expressed as fold change activity over pGL3-basic alone. 
**P < 0.01, ***P < 0.001. (n = 3, two-way ANOVA) activity is expressed 
as fold change activity. Over pGL3-basic alone. **P < 0.01, 
***P < 0.001. (n = 3, two-way ANOVA).
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differ from human and mouse counterparts (MacAuley 
et al. 1998), in that they are binucleate as opposed to 
multinucleate and do not possess the increased gene 
number observed in endoreduplicated cells (Wooding 
et al. 2001). Nevertheless, it is clear that regulation of 
cell cycle progression and cyclin signalling pathways 
retain an integral role in the process of cell differentiation 
in the chorionic girdle.
Evidence for trophoblast movement was supported 
by the identification of multiple signalling pathways 
including focal adhesion, Rho signalling and integrin 
signalling. Canonical pathway analysis indicated 
an increase in activity at days 30–31 of pregnancy 
providing evidence of temporally and spatially 
regulated trophoblast movement, distinct from invasion 
of the endometrium which is observed beyond day 34 
of development. Signalling by Rho Family of GTPases 
was the most predominant movement related pathway 
identified in bioinformatics analysis and functional 
assays further supported a role for Rho A signalling in 
equine trophoblast migration. Very little is known about 
the pathways that regulate movement of chorionic girdle 
trophoblast, beyond early work that showed a role for 
metalloproteinases (Vagnoni et  al. 1995). In human 
trophoblast, Rho A mediates EGF-regulated migration 
(Han et  al. 2010). Based on the induction of EGF in 
pregnant endometrium in mare pregnancy (Allen et al. 
2017), it is plausible that this molecular pathway is 
also important for regulating trophoblast migration in 
the mare.
Multiple analyses suggested the integrin signalling 
pathway to be activated increasingly in the chorionic 
girdle between days 27 and 34 of development. Integrin 
α2 (ITGA2) expression was a top 20 upregulated 
gene at day 34 consistent with previous work (Sones 
et  al. 2010). Regulation of binding of collagen and 
laminin is a well-defined role of ITGA2 and as these 
are also known to be expressed in mare endometrium 
(Mansour et  al. 2003). Collectively, this is supportive 
of a role for integrin signalling in invasion of the 
maternal endometrium around day 36 of pregnancy. 
Activation of ERK signalling by integrin pathways is 
thought to play a major role in cell migration, through 
phosphorylation of myosin chains (Kumar 1998). It is 
possible that interactions between integrin and ERK 
signalling is key in co-ordinating the differentiation and 
migration processes in the chorionic girdle. Whether 
the trophoblasts migrate to the apices of the girdle 
folds to differentiate into binucelate eCG-producing 
cells or they first differentiate and later gain the ability 
to move towards chemotactic signals is not clear, but 
this co-ordinated differentiation and cell movement 
during the development of the chorionic girdle is key 
and occurs prior to acquisition of invasive potential by 
trophoblast between days 34 and 38 of pregnancy.
Migration of cancer cells and progression of tumour 
were identified as some of the top regulator effector 
networks in the chorionic girdle at all time points. 
Additionally, the majority of pathways identified in 
KEGG pathway analysis of gene clusters 1 and 7 were 
also cancer signalling pathways, with 13 different 
cancer signalling pathways emerging in total. 
Trophoblasts have been directly compared to cancer 
cells in their ability to proliferate, invade the maternal 
endometrium, establish a blood supply and moderate 
the maternal immune response (Reeves & James 2017). 
However, unlike cancer cells, chorionic girdle cells 
possess an unknown mechanism by which invasion 
is halted, upon formation of the endometrial cups. 
Further, chorionic girdle trophoblast senesce upon 
terminal differentiation, and primary cell cultures have 
not been maintained much beyond 180 days of culture 
(Allen & Moor 1972, Thway et al. 2001). Investigating 
how trophoblast cells regulate their invasion may prove 
highly informative not only in the field of placental 
biology, but also for identification of novel therapeutic 
targets in invasive cancers.
A number of canonical pathways involved in immune 
signalling were identified in analysis of the microarray 
Figure 7 Inhibition of Rho function decreases motility of primary 
equine trophoblast cells. (A) Representative images of scratches at 
time 0 and 24 h in the absence and presence of Rho inhibitor 
(Rhosin, 50 µM). Black lines in each image mark the margins of the 
scratch and show a decreased motility following Rhosin treatment. 
(B) Cumulative data of average distance moved showing significantly 
(P < 0.0001) decreased motility in Rhosin treated cultures compared 
with control. Data shown are mean and standard deviation for 24 
measurements (n = 3 independent experiments in day 34 chorionic 
girdle trophoblast). Scale bar in A represents 200 µm.
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data. These included CD28 signalling, cluster of 
differentiation 40 (CD40) signalling and interleukin 9 
(IL-9) signalling, all of which peaked in activation at day 
34 of pregnancy. Previous work has shown that equine 
trophoblast cells are able to resist immune destruction 
when transplanted across allogenic barriers consistent 
with an inherent ability to modulate the immune 
response (de Mestre et al. 2011). IL-9 secreted by human 
syncytiotrophoblast have been found to play a role in 
regulation of integrins to promote cellular migration 
(Sharma et al. 2016). It is therefore possible that a novel 
role for IL-9 in regulation of endometrial invasion in the 
equine conceptus through either immunomodulation 
and/or upregulation of integrin signalling pathways 
has been identified here. CD40 and CD28 signalling 
pathways are previously undocumented in placental 
trophoblast cells of horse, human or mouse origin with 
further studies required to confirm their activity here. 
CD40 is commonly found on antigen presenting cells 
and CD28 on T-helper cells. Upregulation of these 
signalling pathways would be expected in the immune 
cells in the maternal endometrium upon invasion by 
chorionic girdle trophoblasts, and further investigation 
of the possible activity and function of these pathways 
in trophoblast is warranted.
In conclusion, through analysis of microarray 
data using multiple pathway analysis tools, we have 
been able to generate an overall impression of the 
genes and signalling landscape in the chorionic 
girdle within a 7-day period significantly expanding 
our understanding of molecular networks in equine 
trophoblast. Functional assays provided further 
evidence suggesting roles for ELF5 in biochemical 
differentiation of trophoblast, Rho A in trophoblast 
migration and ERK1/2 activity that is likely to mediate 
FGF7 and EGF signalling during chorionic girdle 
development. Interrogation of pathway components 
with in vitro experimentation will further uncover 
which of these pathways are crucial for the processes 
of cell movement, differentiation and invasion not 
only allowing us to gain a more comprehensive 
understanding of trophoblast biology in horses but 
possibly informing future work in other species.
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